New Advances on the Functions of Epidermal Growth Factor Receptor and Ceramides in Skin Cell Differentiation, Disorders and Cancers

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Skin Pharmacology and Physiology

• Publication date

  2004-07-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000078818PMID 15258446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Daily Variations in Skin Surface Properties Using Mixed Model Methodology

  2004cited by this paper
• Identification of Benzene Metabolites in Dermal Fibroblasts as Nonphenolic: Regulation of Cell Viability, Apoptosis, Lipid Peroxidation and Expression of Matrix Metalloproteinase 1 and Elastin by Benzene Metabolites

  2004cited by this paper
• The stratum corneum: structure and function in health and disease

  2004cited by this paper
• Induction of Disease-associated Keratin 16 Gene Expression by Epidermal Growth Factor Is Regulated through Cooperation of Transcription Factors Sp1 and c-Jun*

  2003cited by this paper
• Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis Published, JLR Papers in Press, October 1, 2002. DOI 10.1194/jlr.M200225-JLR200

  2003cited by this paper
• Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma

  2003cited by this paper
• Combinations of anticancer drugs and immunotherapy

  2003cited by this paper
• Abnormal Expression of the Novel Epidermal Enzyme, Glucosylceramide Deacylase, and the Accumulation of its Enzymatic Reaction Product, Glucosylsphingosine, in the Skin of Patients with Atopic Dermatitis

  2003cited by this paper
• Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma.

  2003cited by this paper
• Les lipides cutans : de la physiologie la clinique

  2003cited by this paper
• Cloning and Characterization of a Mouse Endoplasmic Reticulum Alkaline Ceramidase

  2003cited by this paper
• Barrier function of the skin: "la raison d'être" of the epidermis.

  2003cited by this paper
• Alteration and Significance of Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor in Psoriatic Epidermis

  2003cited by this paper
• The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs

  2003cited by this paper
• Cloning and Characterization of a Mouse Endoplasmic Reticulum Alkaline Ceramidase AN ENZYME THAT PREFERENTIALLY REGULATES METABOLISM OF VERY LONG CHAIN CERAMIDES*

  2003cited by this paper
• Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase.

  2003cited by this paper
• Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes.

  2003cited by this paper
• L-Serine and glycine based ceramide analogues as transdermal permeation enhancers: polar head size and hydrogen bonding.

  2003cited by this paper
• Photodynamic Therapy for the Treatment of Skin Disease

  2003cited by this paper
• Prognostic Value of Ki‐67, CD31 and Epidermal Growth Factor Receptor Expression in Basal Cell Carcinoma

  2003cited by this paper
• [Classification and stages of skin melanoma].

  2003cited by this paper
• Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis

  2003cited by this paper
• [Treatment of melanoma].

  2003cited by this paper
• Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.

  2003cited by this paper
• Mad dogs, Englishmen and apoptosis: The role of cell death in UV-induced skin cancer

  2003cited by this paper
• [Biochemical analysis of epidermal lipids].

  2003cited by this paper
• Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.

  2003cited by this paper
• Ceramides and the stratum corneum: structure, function, and new methods to promote repair

  2003cited by this paper
• Analyse biochimique des lipides épidermiques

  2003cited by this paper
• Temozolomide in combination with interferon α‐2b in patients with metastatic melanoma

  2003cited by this paper
• UV-induced skin damage.

  2003cited by this paper
• c-Jun regulates eyelid closure and skin tumor development through EGFR signaling.

  2003cited by this paper
• Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway

  2003cited by this paper
• Adjuvant therapy for high‐risk primary and resected metastatic melanoma

  2003cited by this paper
• Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.

  2003cited by this paper
• Conséquences fonctionnelles des perturbations des lipides cutanés

  2003cited by this paper
• Thin Melanomas: Predictive Lethal Characteristics From a 30-Year Clinical Experience

  2003cited by this paper
• Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

  2003cited by this paper
• Surgical performance for specialties undertaking temporal artery biopsies: who should perform them?

  2003cited by this paper
• Flotillas of lipid rafts in transit amplifying cell-like keratinocytes.

  2003cited by this paper
• [Functional consequences of cutaneous lipid perturbation].

  2003cited by this paper
• Dendritic cell-based cancer immunotherapy.

  2003cited by this paper
• [Cutaneous lipids: from physiology to the clinical].

  2003cited by this paper
• Factors Affecting the Formation of a Skin Reservoir for Topically Applied Solutes

  2003cited by this paper
• EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation.

  2003cited by this paper
• Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function.

  2003cited by this paper
• The novel retinoid AHPN/CD437 induces a rapid but incomplete apoptotic response in human myeloma cells.

  2003cited by this paper
• New Advances on Prostate Carcinogenesis and Therapies: Involvement of EGF-EGFR Transduction System

  2003cited by this paper
• Improving Survival in Patients with High-Risk and Metastatic Melanoma

  2003cited by this paper
• Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients.

  2003cited by this paper
• Epidemiology of cutaneous melanoma and non‐melanoma skin cancer in Schleswig‐Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer)

  2003cited by this paper
• Oncogenes in melanoma

  2003cited by this paper
• Synergy between tumor immunotherapy and antiangiogenic therapy.

  2003cited by this paper
• Structure of the skin barrier and its modulation by vesicular formulations.

  2003cited by this paper
• Ceramides and Skin Function

  2003cited by this paper
• Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy

  2003cited by this paper
• p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma

  2002cited by this paper
• Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.

  2002cited by this paper
• A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.

  2002cited by this paper
• New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.

  2002cited by this paper
• Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans.

  2002cited by this paper
• A Comparative Review of Melanocytic Neoplasms

  2002cited by this paper
• Mitogen-actived protein kinase activation is an early event in melanoma progression.

  2002cited by this paper
• Erfahrungen mit der Therapie des metastasierten malignen Melanoms im Stadium IV mittels Polychemoimmuntherapie nach dem “Legha-Protokoll”

  2002cited by this paper
• Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

  2002cited by this paper
• Sphingolipid metabolism during epidermal barrier development in mice DOI 10.1194/jlr.M200208-JLR200

  2002cited by this paper
• Bcl‐2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes

  2002cited by this paper
• Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation.

  2002cited by this paper
• Biochemotherapy for advanced melanoma: maybe it is real.

  2002cited by this paper
• Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function

  2002cited by this paper
• The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.

  2002cited by this paper
• The CLN3 gene is a novel molecular target for cancer drug discovery.

  2002cited by this paper
• Interleukin-1-stimulated secretion of interleukin-8 and growth-related oncogene-alpha demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis.

  2002cited by this paper
• Effect of a lipid‐rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction

  2002cited by this paper
• Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein.

  2002cited by this paper
• Flavonoid Antioxidant Silymarin and Skin Cancer

  2002cited by this paper
• Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation.

  2002cited by this paper
• A comparative review of cutaneous pH.

  2002cited by this paper
• Cholesterol-rich plasma membrane domains (lipid rafts) in keratinocytes: importance in the baseline and UVA-induced generation of reactive oxygen species.

  2002cited by this paper
• Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis.

  2002cited by this paper
• Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus.

  2002cited by this paper
• Characterization of Reconstructed Skin Models

  2002cited by this paper
• Influence of different ceramides on the structure of in vitro model lipid systems of the stratum corneum lipid matrix.

  2002cited by this paper
• Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin.

  2002cited by this paper
• [Experiences with therapy of stage IV metastatic malignant melanoma with "Legha Protocol" polychemoimmunotherapy].

  2002cited by this paper
• Human epidermal glucosylceramides are major precursors of stratum corneum ceramides.

  2002cited by this paper
• Dermatological aspects of angiogenesis

  2002cited by this paper
• Interferon as adjuvant treatment for melanoma.

  2002cited by this paper
• FTIR spectroscopic analyses of the temperature and pH influences on stratum corneum lipid phase behaviors and interactions.

  2002cited by this paper
• Intermediate- and high-risk melanoma

  2002cited by this paper
• Repair of acetone‐ and sodium lauryl sulphate‐damaged human skin barrier function using topically applied emulsions containing barrier lipids

  2002cited by this paper
• NHE1 Regulates the Stratum Corneum Permeability Barrier Homeostasis

  2002cited by this paper
• Nitric oxide‐peroxynitrite‐poly(ADP‐ribose) polymerase pathway in the skin

  2002cited by this paper
• Effects of C2-ceramide on the Malme-3M melanoma cell line.

  2002cited by this paper
• Functional roles of Akt signaling in mouse skin tumorigenesis

  2002cited by this paper
• Malignant melanoma: treatments emerging, but early detection is still key.

  2002cited by this paper
• The CLN 3 Gene is a Novel Molecular Target for Cancer Drug Discovery 1

  2002cited by this paper
• Detergent-induced epidermal barrier dysfunction and its prevention.

  2002cited by this paper
• The role of interleukin-8 in the initiation and progression of human cutaneous melanoma.

  2002cited by this paper
• The aged epidermal permeability barrier: basis for functional abnormalities.

  2002cited by this paper

• Prenatal arsenic exposure alters keratinocyte stem cell fate through persistent activation of IGF2R‐MAPK cascade leading to aggravated skin carcinogenesis in mice offspring

  2024cites this paper
• Updates on the mechanisms of toxicities associated with monoclonal antibodies targeting growth factor signaling and immune cells in cancer

  2024cites this paper
• A network pharmacology‐based study of the potential targets and mechanisms of action of Qibao Meiran Dan in delaying skin aging

  2022cites this paper
• Highlights on Selected Growth Factors and their Receptors as Promising Anticancer Drug Targets.

  2021cites this paper
• Cutaneous Reactions to Targeted Anticancer Agents

  2018cites this paper
• Moisturizers are effective in the treatment of xerosis irrespectively from their particular formulation: results from a prospective, randomized, double‐blind controlled trial

  2016cites this paper
• “STEM CELL THERAPY”-A REVIEW

  2016cites this paper
• Stem Cells in the Skin

  2016cites this paper
• Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis

  2015cites this paper
• Assessment of skin-related toxicity in patients with metastatic colorectal cancer treated with cetuximab.

  2014cites this paper
• QChIPat: a quantitative method to identify distinct binding patterns for two biological ChIP-seq samples in different experimental conditions

  2013cites this paper
• Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor

  2012cites this paper
• Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.

  2012cites this paper
• Abnormal expression of MAPK, EGFR, CK17 and TGk in the skin lesions of chloracne patients exposed to dioxins.

  2011cites this paper
• Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study

  2010cites this paper
• Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines

  2010cites this paper
• Molecular Targeted Therapies for Solid Tumors: Management of Side Effects

  2009cites this paper
• Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies

  2009influential citation
• Antigen expression of human eccrine sweat glands

  2009cites this paper
• Tumor Necrosis Factor-A and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

  2009cites this paper
• Stem cell therapy for hereditary breast cancer

  2009cites this paper
• Critical Roles of Tumorigenic and Migrating Cancer Stem/Progenitor Cells in Cancer Progression and their Therapeutic Implications

  2009cites this paper
• Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies

  2008cites this paper
• Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

  2008cites this paper
• Gonadotropins and ovarian cancer.

  2007cites this paper
• Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.

  2007cites this paper
• Oncogene Coexpression in Mesenchymal Neoplasia Correlates with EGF Transcription

  2007cites this paper
• Effects of brief cutaneous JP-8 jet fuel exposures on time course of gene expression in the epidermis.

  2007cites this paper
• Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies

  2006cites this paper
• Dioxin‐induced chloracne – reconstructing the cellular and molecular mechanisms of a classic environmental disease

  2006cites this paper
• Hair Follicles – A Long-Term Reservoir for Drug Delivery

  2006cites this paper
• Biología, patobiología, bioclínica y farmacoterapéutica del factor de crecimiento epitelial (EGF) y el estrés celular en la especie humana

  2006cites this paper
• Mechanisms of cutaneous toxicities to EGFR inhibitors

  2006cites this paper
• Sirolimus-Induced Acneiform Eruption

  2005cites this paper
• The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes

  2005cites this paper
• Kinase Inhibitor-Induced Pustules

  2005cites this paper
• Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors.

  2005cites this paper